FARMAK, a.s. was established as an employee joint stock company in 1992. The current production is focused on the production of generic medicinal products. A new research and development workplace for the hydrogenation process will be created as part of the project. The new modern equipment will then contribute to increasing the competitiveness of the applicant while at the same time allowing the development cycle of new products to be shortened. This plays a very important role in the company’s export strategy. and.